Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Neuronal Markers Market Research Report 2025

Global Neuronal Markers Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-01

Pages: 76 Pages

Report ld: 3459675

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Neuronal Markers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.

North American market for Neuronal Markers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Neuronal Markers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Neuronal Markers include Athena Diagnostics, Myriad RBM, AbaStar MDx, QIAGEN, Thermo Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Neuronal Markers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuronal Markers.

The Neuronal Markers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuronal Markers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuronal Markers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Athena Diagnostics

Myriad RBM

AbaStar MDx

QIAGEN

Thermo Fisher Scientific

Segment by Type

Imaging Biomarkers

Metabolomics Biomarkers

Proteomic Biomarkers

Genomics Biomarkers

Segment by Application

Hospital

Clinic

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Neuronal Markers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Neuronal Markers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Neuronal Markers Market Overview

1.1 Product Definition

1.2 Neuronal Markers by Type

1.2.1 Global Neuronal Markers Market Value Comparison by Type (2024 VS 2031)

1.2.2 Imaging Biomarkers

1.2.3 Metabolomics Biomarkers

1.2.4 Proteomic Biomarkers

1.2.5 Genomics Biomarkers

1.3 Neuronal Markers by Application

1.3.1 Global Neuronal Markers Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Neuronal Markers Market Size Estimates and Forecasts

1.4.1 Global Neuronal Markers Revenue 2020-2031

1.4.2 Global Neuronal Markers Sales 2020-2031

1.4.3 Global Neuronal Markers Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Neuronal Markers Market Competition by Manufacturers

2.1 Global Neuronal Markers Sales Market Share by Manufacturers (2020-2025)

2.2 Global Neuronal Markers Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Neuronal Markers Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Neuronal Markers, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Neuronal Markers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Neuronal Markers, Product Type & Application

2.7 Global Key Manufacturers of Neuronal Markers, Date of Enter into This Industry

2.8 Global Neuronal Markers Market Competitive Situation and Trends

2.8.1 Global Neuronal Markers Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Neuronal Markers Players Market Share by Revenue

2.8.3 Global Neuronal Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Neuronal Markers Market Scenario by Region

3.1 Global Neuronal Markers Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Neuronal Markers Sales by Region: 2020-2031

3.2.1 Global Neuronal Markers Sales by Region: 2020-2025

3.2.2 Global Neuronal Markers Sales by Region: 2026-2031

3.3 Global Neuronal Markers Revenue by Region: 2020-2031

3.3.1 Global Neuronal Markers Revenue by Region: 2020-2025

3.3.2 Global Neuronal Markers Revenue by Region: 2026-2031

3.4 North America Neuronal Markers Market Facts & Figures by Country

3.4.1 North America Neuronal Markers Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Neuronal Markers Sales by Country (2020-2031)

3.4.3 North America Neuronal Markers Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Neuronal Markers Market Facts & Figures by Country

3.5.1 Europe Neuronal Markers Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Neuronal Markers Sales by Country (2020-2031)

3.5.3 Europe Neuronal Markers Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Neuronal Markers Market Facts & Figures by Region

3.6.1 Asia Pacific Neuronal Markers Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Neuronal Markers Sales by Region (2020-2031)

3.6.3 Asia Pacific Neuronal Markers Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Neuronal Markers Market Facts & Figures by Country

3.7.1 Latin America Neuronal Markers Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Neuronal Markers Sales by Country (2020-2031)

3.7.3 Latin America Neuronal Markers Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Neuronal Markers Market Facts & Figures by Country

3.8.1 Middle East and Africa Neuronal Markers Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Neuronal Markers Sales by Country (2020-2031)

3.8.3 Middle East and Africa Neuronal Markers Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Neuronal Markers Sales by Type (2020-2031)

4.1.1 Global Neuronal Markers Sales by Type (2020-2025)

4.1.2 Global Neuronal Markers Sales by Type (2026-2031)

4.1.3 Global Neuronal Markers Sales Market Share by Type (2020-2031)

4.2 Global Neuronal Markers Revenue by Type (2020-2031)

4.2.1 Global Neuronal Markers Revenue by Type (2020-2025)

4.2.2 Global Neuronal Markers Revenue by Type (2026-2031)

4.2.3 Global Neuronal Markers Revenue Market Share by Type (2020-2031)

4.3 Global Neuronal Markers Price by Type (2020-2031)

5 Segment by Application

5.1 Global Neuronal Markers Sales by Application (2020-2031)

5.1.1 Global Neuronal Markers Sales by Application (2020-2025)

5.1.2 Global Neuronal Markers Sales by Application (2026-2031)

5.1.3 Global Neuronal Markers Sales Market Share by Application (2020-2031)

5.2 Global Neuronal Markers Revenue by Application (2020-2031)

5.2.1 Global Neuronal Markers Revenue by Application (2020-2025)

5.2.2 Global Neuronal Markers Revenue by Application (2026-2031)

5.2.3 Global Neuronal Markers Revenue Market Share by Application (2020-2031)

5.3 Global Neuronal Markers Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Athena Diagnostics

6.1.1 Athena Diagnostics Company Information

6.1.2 Athena Diagnostics Description and Business Overview

6.1.3 Athena Diagnostics Neuronal Markers Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Athena Diagnostics Neuronal Markers Product Portfolio

6.1.5 Athena Diagnostics Recent Developments/Updates

6.2 Myriad RBM

6.2.1 Myriad RBM Company Information

6.2.2 Myriad RBM Description and Business Overview

6.2.3 Myriad RBM Neuronal Markers Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Myriad RBM Neuronal Markers Product Portfolio

6.2.5 Myriad RBM Recent Developments/Updates

6.3 AbaStar MDx

6.3.1 AbaStar MDx Company Information

6.3.2 AbaStar MDx Description and Business Overview

6.3.3 AbaStar MDx Neuronal Markers Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AbaStar MDx Neuronal Markers Product Portfolio

6.3.5 AbaStar MDx Recent Developments/Updates

6.4 QIAGEN

6.4.1 QIAGEN Company Information

6.4.2 QIAGEN Description and Business Overview

6.4.3 QIAGEN Neuronal Markers Sales, Revenue and Gross Margin (2020-2025)

6.4.4 QIAGEN Neuronal Markers Product Portfolio

6.4.5 QIAGEN Recent Developments/Updates

6.5 Thermo Fisher Scientific

6.5.1 Thermo Fisher Scientific Company Information

6.5.2 Thermo Fisher Scientific Description and Business Overview

6.5.3 Thermo Fisher Scientific Neuronal Markers Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Thermo Fisher Scientific Neuronal Markers Product Portfolio

6.5.5 Thermo Fisher Scientific Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Neuronal Markers Industry Chain Analysis

7.2 Neuronal Markers Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Neuronal Markers Production Mode & Process Analysis

7.4 Neuronal Markers Sales and Marketing

7.4.1 Neuronal Markers Sales Channels

7.4.2 Neuronal Markers Distributors

7.5 Neuronal Markers Customer Analysis

8 Neuronal Markers Market Dynamics

8.1 Neuronal Markers Industry Trends

8.2 Neuronal Markers Market Drivers

8.3 Neuronal Markers Market Challenges

8.4 Neuronal Markers Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Neuronal Markers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Neuronal Markers Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Neuronal Markers Market Competitive Situation by Manufacturers in 2024

Table 4. Global Neuronal Markers Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Neuronal Markers Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Neuronal Markers Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Neuronal Markers Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Neuronal Markers Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Neuronal Markers, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Neuronal Markers, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Neuronal Markers, Product Type & Application

Table 12. Global Key Manufacturers of Neuronal Markers, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Neuronal Markers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuronal Markers as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Neuronal Markers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Neuronal Markers Sales by Region (2020-2025) & (K Units)

Table 18. Global Neuronal Markers Sales Market Share by Region (2020-2025)

Table 19. Global Neuronal Markers Sales by Region (2026-2031) & (K Units)

Table 20. Global Neuronal Markers Sales Market Share by Region (2026-2031)

Table 21. Global Neuronal Markers Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Neuronal Markers Revenue Market Share by Region (2020-2025)

Table 23. Global Neuronal Markers Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Neuronal Markers Revenue Market Share by Region (2026-2031)

Table 25. North America Neuronal Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Neuronal Markers Sales by Country (2020-2025) & (K Units)

Table 27. North America Neuronal Markers Sales by Country (2026-2031) & (K Units)

Table 28. North America Neuronal Markers Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Neuronal Markers Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Neuronal Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Neuronal Markers Sales by Country (2020-2025) & (K Units)

Table 32. Europe Neuronal Markers Sales by Country (2026-2031) & (K Units)

Table 33. Europe Neuronal Markers Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Neuronal Markers Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Neuronal Markers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Neuronal Markers Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Neuronal Markers Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Neuronal Markers Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Neuronal Markers Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Neuronal Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Neuronal Markers Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Neuronal Markers Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Neuronal Markers Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Neuronal Markers Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Neuronal Markers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Neuronal Markers Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Neuronal Markers Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Neuronal Markers Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Neuronal Markers Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Neuronal Markers Sales (K Units) by Type (2020-2025)

Table 51. Global Neuronal Markers Sales (K Units) by Type (2026-2031)

Table 52. Global Neuronal Markers Sales Market Share by Type (2020-2025)

Table 53. Global Neuronal Markers Sales Market Share by Type (2026-2031)

Table 54. Global Neuronal Markers Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Neuronal Markers Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Neuronal Markers Revenue Market Share by Type (2020-2025)

Table 57. Global Neuronal Markers Revenue Market Share by Type (2026-2031)

Table 58. Global Neuronal Markers Price (US$/Unit) by Type (2020-2025)

Table 59. Global Neuronal Markers Price (US$/Unit) by Type (2026-2031)

Table 60. Global Neuronal Markers Sales (K Units) by Application (2020-2025)

Table 61. Global Neuronal Markers Sales (K Units) by Application (2026-2031)

Table 62. Global Neuronal Markers Sales Market Share by Application (2020-2025)

Table 63. Global Neuronal Markers Sales Market Share by Application (2026-2031)

Table 64. Global Neuronal Markers Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Neuronal Markers Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Neuronal Markers Revenue Market Share by Application (2020-2025)

Table 67. Global Neuronal Markers Revenue Market Share by Application (2026-2031)

Table 68. Global Neuronal Markers Price (US$/Unit) by Application (2020-2025)

Table 69. Global Neuronal Markers Price (US$/Unit) by Application (2026-2031)

Table 70. Athena Diagnostics Company Information

Table 71. Athena Diagnostics Description and Business Overview

Table 72. Athena Diagnostics Neuronal Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Athena Diagnostics Neuronal Markers Product

Table 74. Athena Diagnostics Recent Developments/Updates

Table 75. Myriad RBM Company Information

Table 76. Myriad RBM Description and Business Overview

Table 77. Myriad RBM Neuronal Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Myriad RBM Neuronal Markers Product

Table 79. Myriad RBM Recent Developments/Updates

Table 80. AbaStar MDx Company Information

Table 81. AbaStar MDx Description and Business Overview

Table 82. AbaStar MDx Neuronal Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. AbaStar MDx Neuronal Markers Product

Table 84. AbaStar MDx Recent Developments/Updates

Table 85. QIAGEN Company Information

Table 86. QIAGEN Description and Business Overview

Table 87. QIAGEN Neuronal Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. QIAGEN Neuronal Markers Product

Table 89. QIAGEN Recent Developments/Updates

Table 90. Thermo Fisher Scientific Company Information

Table 91. Thermo Fisher Scientific Description and Business Overview

Table 92. Thermo Fisher Scientific Neuronal Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Thermo Fisher Scientific Neuronal Markers Product

Table 94. Thermo Fisher Scientific Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Neuronal Markers Distributors List

Table 98. Neuronal Markers Customers List

Table 99. Neuronal Markers Market Trends

Table 100. Neuronal Markers Market Drivers

Table 101. Neuronal Markers Market Challenges

Table 102. Neuronal Markers Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Neuronal Markers

Figure 2. Global Neuronal Markers Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neuronal Markers Market Share by Type: 2024 & 2031

Figure 4. Imaging Biomarkers Product Picture

Figure 5. Metabolomics Biomarkers Product Picture

Figure 6. Proteomic Biomarkers Product Picture

Figure 7. Genomics Biomarkers Product Picture

Figure 8. Global Neuronal Markers Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Neuronal Markers Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Others

Figure 13. Global Neuronal Markers Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Neuronal Markers Market Size (2020-2031) & (US$ Million)

Figure 15. Global Neuronal Markers Sales (2020-2031) & (K Units)

Figure 16. Global Neuronal Markers Average Price (US$/Unit) & (2020-2031)

Figure 17. Neuronal Markers Report Years Considered

Figure 18. Neuronal Markers Sales Share by Manufacturers in 2024

Figure 19. Global Neuronal Markers Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Neuronal Markers Players: Market Share by Revenue in Neuronal Markers in 2024

Figure 21. Neuronal Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Neuronal Markers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Neuronal Markers Sales Market Share by Country (2020-2031)

Figure 24. North America Neuronal Markers Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Neuronal Markers Sales Market Share by Country (2020-2031)

Figure 28. Europe Neuronal Markers Revenue Market Share by Country (2020-2031)

Figure 29. Germany Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Neuronal Markers Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Neuronal Markers Revenue Market Share by Region (2020-2031)

Figure 36. China Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Neuronal Markers Sales Market Share by Country (2020-2031)

Figure 47. Latin America Neuronal Markers Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Neuronal Markers Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Neuronal Markers Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Neuronal Markers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Neuronal Markers by Type (2020-2031)

Figure 57. Global Revenue Market Share of Neuronal Markers by Type (2020-2031)

Figure 58. Global Neuronal Markers Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Neuronal Markers by Application (2020-2031)

Figure 60. Global Revenue Market Share of Neuronal Markers by Application (2020-2031)

Figure 61. Global Neuronal Markers Price (US$/Unit) by Application (2020-2031)

Figure 62. Neuronal Markers Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Neuronal Markers market? zhanKai

The top companies in the global Neuronal Markers market are Athena Diagnostics、Myriad RBM、AbaStar MDx.

Related Reports

Neuronal Markers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neuronal Markers was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
Global Neuronal Markers Market Research Report 2026
The global Neuronal Markers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 98
USD 2900.00
(Single User License)
Global Neuronal Markers Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neuronal Markers market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 68
USD 4250.00
(Single User License)
Global Neuronal Markers Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neuronal Markers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 112
USD 4900.00
(Single User License)
Neuronal Markers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neuronal Markers was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 90
USD 3950.00
(Single User License)
Global Neuronal Markers Market Research Report 2024
A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Published Date: 2024-02-26
Pages: 78
USD 2900.00
(Single User License)
Neuronal Markers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Published Date: 2024-01-11
Pages: 100
USD 3950.00
(Single User License)

Neuronal Markers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neuronal Markers was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 119
USD 3950.00 (Single User License)
Global Neuronal Markers Market Research Report 2026
The global Neuronal Markers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 98
USD 2900.00 (Single User License)
Global Neuronal Markers Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neuronal Markers market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 68
USD 4250.00 (Single User License)
Global Neuronal Markers Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neuronal Markers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 112
USD 4900.00 (Single User License)
Neuronal Markers- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neuronal Markers was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 90
USD 3950.00 (Single User License)
Global Neuronal Markers Market Research Report 2024
A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Published: 2024-02-26
Pages: 78
USD 2900.00 (Single User License)
Neuronal Markers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Published: 2024-01-11
Pages: 100
USD 3950.00 (Single User License)